Bronchopneumopathie chronique obstructive

The European Respiratory Congress highlighted some essentials points in the field of COPD. Technology is on the agenda with promising advances in lung volume reduction therapy with the use of intrabronchial coils or by non-invasive ventilation with the use of high pressures. The issue of sanitary safety has pointed the risk of induced pneumonia in patients exposed to inhaled corticosteroids and the possible excess risk of mortality associated with tiotropium by Respimat.